Heart1.com: Great Information, Real Community, Better Living.
 Main Page
 Heart News
Feature Story
 Education Center
 Heart Attack Center
Dr. Tod Engelhardt  Heart

Dr. Tod Engelhardt:
Combating Major Blood Clots.
About Heroes
 Join the Discussion  in  Our Forums
Heart1 Forums
Patient Stories
Online Resources
Video Library
Search the Body1 Network
May 26, 2022  
HEART NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Heart device combines two types of implants

    Heart device combines two types of implants

    May 21, 2002


    Associated Press

    Monday, May 20, 2002

    Washington -- The Food and Drug Administration has approved a new heart implant that combines a souped-up pacemaker to boost the heart's pumping power with a jump-starter that kicks in if the heart stops.

    Guidant Corp.'s Contak CD is the first implanted defibrillator with "cardiac resynchronization," a way to make a struggling heart beat more normally by forcing its main pumping chambers to work together.

    A resynchronizer is already available from Medtronic Inc., and many companies sell implanted defibrillators that jump-start hearts that suddenly stop beating. Guidant's device is the first to combine the two types of implants.

    The caveat: Doctors can't yet tell exactly who will benefit from resynchronization therapy, or how much it will help, said FDA medical reviewer Helen Barold.

    The Contak CD is for advanced heart failure patients who are not adequately helped by medication and need a defibrillator. In studies, some of those patients saw their quality of life and tolerance for exercise improve dramatically, while others saw only a little change.

    "It's very individualized," Barold cautioned. "It's a little bit of a last resort for patients."

    The new defibrillator takes a little longer to put in than traditional ones, she said, because it has an extra lead to snake into the heart.

    Almost 5 million Americans have congestive heart failure, in which a heart weakened by age, damage from a heart attack or some other disease gets flabbier as it struggles to push blood out to the rest of the body. Just half of such patients survive five years. When medications fail, a heart transplant is the only option, but many patients die before getting one.

    For many such patients, the heart's main pumping chambers don't beat together simultaneously and sap the heart's power. Resynchronizers use wires implanted in different spots to make the chambers pump together as they would in a healthy heart.

    Guidant said it will begin selling the new device immediately. The list price will be $44,475 -- about $9,000 more than a regular defibrillator -- but most hospitals don't pay list price and Guidant wouldn't estimate the cost to patients.

    Food and Drug Administration: www.fda.gov Guidant: www.guidant.com

    Last updated: 21-May-02

    Feature Archives

    Heart Disease Patients Need to Exercise to Benefit from the Protective Effects of Wine

    Effective Treatment for Heart Failure Possible Following Discovery of Heart Molecule

    Significant Decrease in Heart Disease after Prison Smoking Bans

    Heart Failure Patients Who Sleep Poorly Are at Double the Risk for Hospitalization

    Long-Term Survival Possible for Pediatric Heart Transplant Patients

    Next 5 Features ...

    More Features ...

    Home About Us Press Jobs Advertise With Us Contact Us
    © 2022 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.